[HTML][HTML] GLP-1 receptor agonists in the treatment of type 2 diabetes–state-of-the-art
MA Nauck, DR Quast, J Wefers, JJ Meier - Molecular metabolism, 2021 - Elsevier
Background GLP-1 receptor agonists (GLP-1 RAs) with exenatide bid first approved to treat
type 2 diabetes in 2005 have been further developed to yield effective compounds …
type 2 diabetes in 2005 have been further developed to yield effective compounds …
[HTML][HTML] 2021 clinical practice guidelines for diabetes mellitus in Korea
Abstract The Committee of Clinical Practice Guidelines of the Korean Diabetes Association
(KDA) updated the previous clinical practice guidelines for Korean adults with diabetes and …
(KDA) updated the previous clinical practice guidelines for Korean adults with diabetes and …
Use of glucagon‐like peptide‐1 receptor agonists and bone fractures: A meta‐analysis of randomized clinical trials (胰高血糖素样肽‐1 受体激动剂的使用与骨折的关系 …
G Mabilleau, A Mieczkowska… - Journal of diabetes, 2014 - Wiley Online Library
摘要背景2 型糖尿病患者的骨折风险较高, 且不依赖于使用降糖药物. 此外, 降糖药物还可以直接
影响骨代谢. 最近, 已经发现使用二肽基肽酶‐4 抑制剂与较低的骨折发生率有关. 本meta …
影响骨代谢. 最近, 已经发现使用二肽基肽酶‐4 抑制剂与较低的骨折发生率有关. 本meta …
American Association of Clinical Endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan—2022 update
L Blonde, GE Umpierrez, SS Reddy, JB McGill… - Endocrine Practice, 2022 - Elsevier
Objective The objective of this clinical practice guideline is to provide updated and new
evidence-based recommendations for the comprehensive care of persons with diabetes …
evidence-based recommendations for the comprehensive care of persons with diabetes …
Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes …
AJ Garber, Y Handelsman, G Grunberger, D Einhorn… - Endocrine Practice, 2020 - Elsevier
ABSTRACT Abbreviations: A1C= hemoglobin A1C; AACE= American Association of Clinical
Endocrinologists; ABCD= adiposity-based chronic disease; ACCORD= Action to Control …
Endocrinologists; ABCD= adiposity-based chronic disease; ACCORD= Action to Control …
Pharmacotherapy of type 2 diabetes: An update and future directions
A DeMarsilis, N Reddy, C Boutari, A Filippaios… - Metabolism, 2022 - Elsevier
Abstract Type 2 diabetes (T2D) is a widely prevalent disease with substantial economic and
social impact for which multiple conventional and novel pharmacotherapies are currently …
social impact for which multiple conventional and novel pharmacotherapies are currently …
Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes …
AJ Garber, MJ Abrahamson, JI Barzilay, L Blonde… - Endocrine Practice, 2019 - Elsevier
ABSTRACT Abbreviations: A1C= hemoglobin A1C; AACE= American Association of Clinical
Endocrinologists; ACCORD= Action to Control Cardiovascular Risk in Diabetes; ACCORD …
Endocrinologists; ACCORD= Action to Control Cardiovascular Risk in Diabetes; ACCORD …
Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the …
SE Inzucchi, RM Bergenstal, JB Buse… - Diabetes …, 2015 - Am Diabetes Assoc
In 2012, the American Diabetes Association (ADA) and the European Association for the
Study of Diabetes (EASD) published a position statement on the management of …
Study of Diabetes (EASD) published a position statement on the management of …
Pharmacological management of obesity: an endocrine Society clinical practice guideline
Objective: To formulate clinical practice guidelines for the pharmacological management of
obesity. Participants: An Endocrine Society-appointed Task Force of experts, a …
obesity. Participants: An Endocrine Society-appointed Task Force of experts, a …
Management of endocrine disease: are all GLP-1 agonists equal in the treatment of type 2 diabetes?
MA Nauck, JJ Meier - European journal of endocrinology, 2019 - academic.oup.com
GLP-1, a peptide hormone secreted from the gut, stimulating insulin and suppressing
glucagon secretion was identified as a parent compound for novel treatments of diabetes …
glucagon secretion was identified as a parent compound for novel treatments of diabetes …